A Real World Approach to LDL cholesterol using PCSK9 inhibitors, October 5 2018 Published 2018-10-05 Download video MP4 360p Recommendations 42:09 New Electrophysiology Frontiers via Genomewide Association Studies, September 28 2018 53:13 Diagnosing and Treating Hyperlipidemia: Recent Evidence and the Role of PCSK9-targeted Therapies 52:48 Global Differences In Heart Failure Etiology, Treatment, and Outcomes 2:12:54 Preventing and Treating Cardiovascular Disease | Lipid Series Part 3 | Dr Thomas Dayspring | Ep 253 23:18 Professor Kausik Ray - PCSK9 inhibition – have we reached the limits of lipid lowering and outcome? 1:00:21 Towards Individualized Care in Thoracic Aortic Disease 1:01:11 Rheumatic Heart Disease and Cardiovascular Capacity Building in Africa 1:02:11 The Role of Non-Statin Therapies in Optimal Cholesterol Management 57:15 TAVR: A Translational Science Perspective 58:42 Robert Lustig - What is Metabolic Syndrome Anyway? 32:56 Non-Statin Therapies for LDL-C Lowering; How to Rationally Use Them 29:03 AMA #15: Fluoride Benefits/Risks & Vagus Nerve Stimulation 1:07:25 The TRUTH Behind Statins: Helpful or Harmful? | Mark Hyman & Aseem Malhotra 02:07 tetralogy of Fallot Similar videos 05:33 A crash course in cholesterol: PCSK9 inhibitors 02:31 What are PCSK9 Inhibitors? (New lipid lowering drugs) 05:41 What is PCSK9 and how PCSK9 inhibitors work? (Mechanism of action) 01:01 Patient Access to PCSK9 Inhibitors 05:03 Are PCSK9 Inhibitors for LDL Cholesterol Safe and Effective? 02:35 Alirocumab – a PCSK9 inhibitor for high cholesterol 03:31 PCSK9 Antibody Dramatically Lowers LDL 02:31 PCSK9 antagonists: A real breakthrough for management of familial hypercholesterolaemia? ESC2016 59:59 Emerging Options for Elevated LDL Cholesterol: Focus on PCSK9 Inhibitors 05:08 Donnette's struggle with PCSK9 approval 01:16 PCSK9 Inhibitors for Cholesterol Lowering 1:05:30 PCSK9 Inhibition: Lowering Lipids and Reducing Cardiovascular Events 26:59 Optimizing LDL-C Lowering With PCSK9 Inhibition 1:03:46 PCSK9 Inhibitors within the Targeted Treatment Approach to Hypercholesterolemia 4/26/16 01:51 Mayo Clinic Experts Advise Caution with New Cholesterol Drugs- PCSK-9 Inhibitors 04:05 KEN SIKARIS e | PCSK9 destroys receptor…so other LDL stay in blood, become small, dense & harmful 26:12 Patient Pulse: An Update on Cholesterol-Lowering Options 11:56 Emergence of PCSK9 Inhibitors More results